← All Pharmacology Flashcard Decks

Pharmacokinetic Principles Flashcards

7 cards from real Pharmacology practice questions. Tap to flip, then mark Knew It or Still Learning — missed cards come back until you master them.

Read the first 7 Pharmacokinetic Principles flashcards as text
  1. A drug with a large volume of distribution (Vd) is most likely doing which of the following?

    Answer: Extensively distributed into peripheral tissues

    A large Vd indicates the drug is widely distributed into tissues beyond the plasma compartment.

  2. Which of the following best defines bioavailability?

    Answer: The fraction of administered drug that reaches systemic circulation unchanged

    Bioavailability (F) is the fraction of an administered dose that reaches systemic circulation in active form.

  3. A drug undergoes significant first-pass metabolism. Which route of administration would BEST avoid this effect?

    Answer: Intramuscular

    Intramuscular injection delivers drug directly into systemic circulation, bypassing hepatic first-pass metabolism entirely.

  4. What is the clinical significance of a drug with a high extraction ratio?

    Answer: Its clearance is highly sensitive to changes in liver blood flow

    High extraction ratio drugs (>0.7) have flow-limited clearance, meaning hepatic blood flow changes significantly affect drug elimination.

  5. A patient has chronic kidney disease with a GFR of 20 mL/min. Which pharmacokinetic parameter is most directly affected?

    Answer: Renal clearance

    Renal clearance is directly reduced in CKD as glomerular filtration rate declines, prolonging drug half-life.

  6. Which of the following is the correct formula for calculating drug half-life (t½)?

    Answer: t½ = 0.693 × Vd / CL

    Half-life is calculated as 0.693 multiplied by volume of distribution divided by clearance.

  7. After how many half-lives does a drug reach approximately 97% of steady-state concentration?

    Answer: 5

    After 5 half-lives, a drug reaches approximately 97% of its steady-state concentration during continuous dosing.